Experience with daptomycin in a tertiary pediatric hospital].

Vancomycin has been considered the treatment of choice especially for methicillin-resistant Staphylococcus aureus (MRSA) infections; but its poor tissue penetration, renal toxicity, and requiring of dosages monitoring, raises the need for new treatment alternatives such as daptomycin. To analyze the safety and effectiveness of daptomycin in children. Children with microbiologically documented infections treated with daptomycin were retrospectively included. The most frequent infections were endocarditis in 9 (32%), sepsis in 4 (14%), bacteremia in 7 (associated with catheter in 3) (25%), osteomyelitis in 3 (10%), peritonitis associated with dialysis in 3 (10%) and suppurative thrombophlebitis in 2 patients (p) (7%). Methicillin-resistant Staphylococcus aureus was the most common pathogen in 18 patients (64%). The indications for daptomycin were due to the failure of conventional treatment in 17 (61%), and the toxicity or intolerance to vancomycin in 11 patients (39%). The average duration of treatment was 19 days (95% ICR 7-42 days). Four patients (14%) completed outpatient treatment, 22 patients had a favorable response (79%). Adverse events were reported in 3 patients (2 creatinine-phosfo-kinase increase) and in one severe skin rash. Daptomycin demonstrated a favorable efficacy and safety in this pediatric population.

Citation

María T Rosanova, Norma Sberna, Claudia Sarkis, Silvina Ruvinsky, Griselda Berberian, Rosa Bologna. Experience with daptomycin in a tertiary pediatric hospital]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 2020 Feb;37(1):19-22

Mesh Tags

Substances

PMID: 32730395

search → result